S. Palanca

发表

B. de Unamuno, S. Palanca, R. Botella, 2015, Current opinion in oncology.

Blocked recombinase polymerase amplification for mutation analysis of PIK3CA gene.

L. Tortajada-Genaro, Á. Maquieira, S. Palanca, 2018, Analytical biochemistry.

Influence of plasmatic lipids on the hemorheological profile in healthy adults.

D. Corella, E. Solá, J. Aznar, 2004, Clinical hemorheology and microcirculation.

Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal Cancer Patients Prospectively Collected.

B. Bellosillo, M. Balbín, E. Díaz-Rubio, 2020, Clinical colorectal cancer.

Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA

C. Lázaro, G. Capellá, L. Feliubadaló, 2016, Breast Cancer Research and Treatment.

The deletion of exons 3–5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families

I. Chirivella, P. Bolufer, E. Barragán, 2013, Familial Cancer.

Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma

C. Orellana, F. Martínez, A. Cañete, 2011, Journal of Cancer Research and Clinical Oncology.

Utility of Next-Generation Sequencing in the Reconstruction of Clonal Architecture in a Patient with an EGFR Mutated Advanced Non-Small Cell Lung Cancer: A Case Report

S. Palanca, Ó. Juan, E. Cases, 2022, Diagnostics.

Targeting Neuroblastoma Stem Cells with Retinoic Acid and Proteasome Inhibitor

D. Burks, A. Cañete, Y. Yáñez, 2013, PloS one.

Mutational Screening of BRCA1/2 Genes as a Predictive Factor for Therapeutic Response in Epithelial Ovarian Cancer: A Consensus Guide from the Spanish Society of Pathology (SEAP-IAP) and the Spanish Society of Human Genetics (AEGH)

J. Cigudosa, F. Rojo, A. Osorio, 2019, Virchows Archiv.

Technical Validation and Clinical Implications of Ultrasensitive PCR Approaches for EGFR-Thr790Met Mutation Detection in Pretreatment FFPE Samples and in Liquid Biopsies from Non-Small Cell Lung Cancer Patients

S. Palanca, J. Gomez-Codina, Ó. Juan, 2022, International journal of molecular sciences.

Novel real-time polymerase chain reaction assay for simultaneous detection of recurrent fusion genes in acute myeloid leukemia.

P. Bolufer, E. Barragán, J. Cervera, 2013, The Journal of molecular diagnostics : JMD.

Increased Tumor Growth Rate and Mesenchymal Properties of NSCLC-Patient-Derived Xenograft Models during Serial Transplantation

C. Jordá, R. Farràs, C. Gandía, 2021, Cancers.

High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations

P. Bolufer, E. Barragán, E. Esteban, 2009, Breast Cancer Research and Treatment.

Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital

E. Barragán, J. Aparicio, B. Laíz, 2019, Cancers.

BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study

J. Benítez, I. Chirivella, D. Salas, 2015, Familial Cancer.

Methylation of tumor suppressor genes is related with copy number aberrations in breast cancer.

Pascual Bolufer, Cristina Alenda, I. Chirivella, 2015, American journal of cancer research.

The deletion of exons 3–5 of BRCA1 is the first founder rearrangement identified in breast and/or ovarian cancer Spanish families

I. Chirivella, P. Bolufer, E. Barragán, 2013, Familial Cancer.

Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS)

I. Chirivella, D. Salas, J. López-Guerrero, 2019, Hereditary cancer in clinical practice.

Study of the S427G polymorphism and of MYBL2 variants in patients with acute myeloid leukemia

P. Bolufer, E. Barragán, J. Cervera, 2016, Leukemia & lymphoma.

Adverse prognostic value of MYBL2 overexpression and association with microRNA-30 family in acute myeloid leukemia patients.

P. Bolufer, E. Barragán, J. Cervera, 2013, Leukemia research.

Early radiological response as predictor of overall survival in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor mutations.

J. Sandoval, A. Lahoz, D. Lorente, 2018, Journal of thoracic disease.

Impact of Molecular Testing Using Next-Generation Sequencing in the Clinical Management of Patients with Non-Small Cell Lung Cancer in a Public Healthcare Hospital

S. Palanca, J. Gomez-Codina, Ó. Juan, 2023, Cancers.

Cost-Effectiveness of Next-Generation Sequencing Versus Single-Gene Testing for the Molecular Diagnosis of Patients With Metastatic Non–Small-Cell Lung Cancer From the Perspective of Spanish Reference Centers

F. López-Ríos, E. de Álava, L. Mezquita, 2023, JCO precision oncology.

Immunohistochemical, genetic and epigenetic profiles of hereditary and triple negative breast cancers. Relevance in personalized medicine.

I. Chirivella, D. Salas, P. Bolufer, 2015, American journal of cancer research.

Clinical Utility of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia Diagnostics.

E. Barragán, J. Cervera, M. Sanz, 2019, The Journal of molecular diagnostics : JMD.

High-resolution melting analysis for rapid screening of and Spanish mutations

P. Bolufer, E. Barragán, E. Esteban, 2020 .

TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients

M. Bermúdez, A. Cañete, D. Hervás, 2016, Journal of Cancer Research and Clinical Oncology.

Rheological red blood cell behaviour in minor α-thalassaemia carriers.

A. Vayá, B. Laíz, M. Suescún, 2011, Clinical hemorheology and microcirculation.

Design and Validation of a Custom Next-Generation Sequencing Panel in Pediatric Acute Lymphoblastic Leukemia

E. Barragán, E. Such, S. Palanca, 2023, International journal of molecular sciences.

Update on melanoma epigenetics

B. de Unamuno, S. Palanca, R. Botella, 2015, Current opinion in oncology.